Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2021 | Improving enrolment diversity in clinical trials for breast cancer

Mark Lythgoe, MD, Imperial College London & Hammersmith Hospital, London, UK, discusses how diversity and inclusion of minority populations can be improved in clinical trial enrollment, in particular for patients with triple-negative breast cancer. This interview took place at the virtual European Society for Medical Oncology (ESMO) Breast Cancer Congress 2021.